Stocktoria
Aier Eye Hospital Group Co., Ltd. 300015.SZ
Aier Eye Hospital Group Co., Ltd. (300015.SZ) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 1.92% (safety: moderate). FY2025 revenue was CN¥22.4B at a 14.5% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 46 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.053 |
| Retained earnings / assets | 0.296 |
| EBIT / assets | 0.134 |
| Equity / liabilities | 1.655 |
FAQ
Is 300015.SZ financially healthy?
Aier Eye Hospital Group Co., Ltd.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does 300015.SZ pay a dividend, and is it safe?
Yes. Aier Eye Hospital Group Co., Ltd. pays a dividend yielding about 1.92% with a 47.1% payout ratio, rated “moderate” for safety.
How profitable is 300015.SZ?
In FY2025, Aier Eye Hospital Group Co., Ltd. had a net margin of 14.5% and a return on equity of 14.7%.
Source: company filings via Yahoo Finance · CN · as of 2025-12-31. Figures in CNY; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.